Literature DB >> 12548205

Genital tract and plasma human immunodeficiency virus viral load throughout the menstrual cycle in women who are infected with ovulatory human immunodeficiency virus.

Deborah M Money1, Yasmin Y Arikan, Valencia Remple, Chris Sherlock, Kevin Craib, Patricia Birch, David R Burdge.   

Abstract

OBJECTIVE: The purpose of this study was to determine the vaginal, cervical, and plasma viral load through the menstrual cycle in women who are positive for human immunodeficiency virus. STUDY
DESIGN: A prospective cohort study was performed on 14 women with ovulatory menstrual cycles who have human immunodeficiency virus. Duplicate cervical and vaginal viral load samples (n = 301) were taken at four stages (menstrual, follicular, periovulatory, and luteal) of two consecutive cycles.
RESULTS: Participant characteristics were mean age of 32.7 years, median human immunodeficiency virus helper cell count value of 355, and median plasma viral load of 24,000 copies/mL. Through the menstrual cycle, there was no statistically significant difference in plasma viral load, but there was a significant decrease in genital tract viral load at the periovulatory phase (vagina, P =.018; cervix, P =.007). Vaginal and cervical viral load were correlated (r = 0.582, P <.001).
CONCLUSION: Although the plasma viral load remained constant throughout the menstrual cycle, the genital viral load decreased at the periovulatory phase. These results suggest that local factors may affect the genital viral load compartment independent of plasma viral load.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12548205     DOI: 10.1067/mob.2003.65

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  11 in total

1.  Increased levels of HIV-1-infected cells in endocervical secretions after the luteinizing hormone surge.

Authors:  Sarah Benki; Sara B Mostad; Barbra A Richardson; Kishorchandra Mandaliya; Joan K Kreiss; Julie Overbaugh
Journal:  J Acquir Immune Defic Syndr       Date:  2008-04-15       Impact factor: 3.731

2.  17β-Estradiol inhibits HIV-1 by inducing a complex formation between β-catenin and estrogen receptor α on the HIV promoter to suppress HIV transcription.

Authors:  Erika L Szotek; Srinivas D Narasipura; Lena Al-Harthi
Journal:  Virology       Date:  2013-06-12       Impact factor: 3.616

Review 3.  Sexual dimorphism in HIV-1 infection.

Authors:  Anne Rechtien; Marcus Altfeld
Journal:  Semin Immunopathol       Date:  2018-10-01       Impact factor: 9.623

Review 4.  Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection.

Authors:  Zdenek Hel; Elizabeth Stringer; Jiri Mestecky
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

5.  Fragility fractures and bone mineral density in HIV positive women: a case-control population-based study.

Authors:  J Prior; D Burdge; E Maan; R Milner; C Hankins; M Klein; S Walmsley
Journal:  Osteoporos Int       Date:  2007-07-31       Impact factor: 4.507

6.  Use of Sno Strip filter-paper wicks for collection of genital-tract samples allows reproducible determination of human immunodeficiency virus type 1 (HIV-1) RNA viral load with a commercial HIV-1 viral load assay.

Authors:  Christopher H Sherlock; Paula M Lott; Deborah M Money; Linda Merrick; Yasemin Arikan; Valencia P Remple; Kevin Craib; David R Burdge
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

7.  Adult male circumcision does not reduce the risk of incident Neisseria gonorrhoeae, Chlamydia trachomatis, or Trichomonas vaginalis infection: results from a randomized, controlled trial in Kenya.

Authors:  Supriya D Mehta; Stephen Moses; Kawango Agot; Corette Parker; Jeckoniah O Ndinya-Achola; Ian Maclean; Robert C Bailey
Journal:  J Infect Dis       Date:  2009-08-01       Impact factor: 5.226

8.  HIV-1 genital shedding is suppressed in the setting of high genital antiretroviral drug concentrations throughout the menstrual cycle.

Authors:  Anandi N Sheth; Tammy Evans-Strickfaden; Richard Haaland; Amy Martin; Chelsea Gatcliffe; Adebola Adesoye; Michael W Omondi; L Davis Lupo; Damien Danavall; Kirk Easley; Cheng-Yen Chen; Chou-Pong Pau; Clyde Hart; Igho Ofotokun
Journal:  J Infect Dis       Date:  2014-03-18       Impact factor: 5.226

9.  Lower levels of HIV-2 than HIV-1 in the female genital tract: correlates and longitudinal assessment of viral shedding.

Authors:  Stephen E Hawes; Papa Salif Sow; Joshua E Stern; Cathy W Critchlow; Geoffrey S Gottlieb; Nancy B Kiviat
Journal:  AIDS       Date:  2008-11-30       Impact factor: 4.177

10.  The X awakens: multifactorial ramifications of sex-specific differences in HIV-1 infection.

Authors:  Sven Hagen; Marcus Altfeld
Journal:  J Virus Erad       Date:  2016-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.